Search
forResearch 8 of 380
- 312 CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
- 924 Efficient genome editing using CRISPR/Cas9 ribonucleoprotein approach in iPS cells for recessive dystrophic epidermolysis bullosa
- 314 Molecular genetic dissection of ILVEN leads to successful targeted therapy
- 316 Specialized ribosomes in human dermal fibroblast senescence
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- 313 Different polyamine levels in the vertex and occipital hair of pattern hair loss patients
- Industry updates in advanced therapy medicinal products and regenerative medicine – March 2026
- Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →